Evidence map›Paper›PMID 30226122›Full record

ArticleInfection control and hospital epidemiology2018

Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU.

Ibukunoluwa C Akinboyo, Annie Voskertchian, Gezahegn Gorfu, Joshua F Betz, Tracy L Ross, Karen C Carroll, Aaron M Milstone

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Impact of methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  3. Article
  4. Microbiome dysbiosis: a modifiable state and target to prevent Staphylococcus aureus infections and other diseases in neonates.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  5. A tale of two intensive care units (ICUs): BaselineInfection control and hospital epidemiology · 2023
    Article
  6. Reducing Staphylococcus aureus infections in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  7. Management and Prevention of Staphylococcus aureus Infections in Children.Infectious disease clinics of North America · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ibukunoluwa C Akinboyo1Division of Infectious Diseases,Department of Pediatrics,Johns Hopkins UniversitySchool of Medicine,Baltimore,Maryland.ORCID 0000-0002-0839-568X
Annie Voskertchian1Division of Infectious Diseases,Department of Pediatrics,Johns Hopkins UniversitySchool of Medicine,Baltimore,Maryland.
Gezahegn Gorfu2Department of Clinical Laboratory Science,College of Nursing and Allied Health Sciences,Howard University,Washington,DC.
Joshua F Betz3Department of Biostatistics,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
Tracy L Ross4Division of Medical Microbiology,Department of Pathology,The Johns Hopkins Hospital,Baltimore,Maryland.
Karen C Carroll4Division of Medical Microbiology,Department of Pathology,The Johns Hopkins Hospital,Baltimore,Maryland.
Aaron M Milstone1Division of Infectious Diseases,Department of Pediatrics,Johns Hopkins UniversitySchool of Medicine,Baltimore,Maryland.
Johns Hopkins University · USJohns Hopkins Hospital · USHoward University · US

Funding

Research Training in Pediatric Infectious DiseasesT32AI052071 · NIAID · JOHNS HOPKINS UNIVERSITY · PI AARON M MILSTONE · 2002 to 2026
$5.2M
Decreasing Neonatal Staphylococcus aureus Disease Through Parental InterventionR01HS022872 · AHRQ · JOHNS HOPKINS UNIVERSITY · PI MILSTONE, AARON M · 2014 to 2017
$1.9M
AHRQ HHS R01 HS022872NIAID NIH HHS T32 AI052071
6 · The paper itself

Abstract

objectivesTo examine neonatal risk factors associated with recurrent Staphylococcus aureus colonization and to determine the genetic relatedness of S. aureus strains cultured from neonates before and after decolonization.Study designSingle-center retrospective cohort study of neonates admitted to the neonatal intensive care unit (NICU) from April 2013 to December 2015, during which weekly nasal cultures from hospitalized NICU patients were routinely obtained for S. aureus surveillance.

settingJohns Hopkins Hospital's 45-bed level IV NICU in Baltimore, Maryland.

methodsDemographics and clinical data were collected on all neonates admitted to the NICU with S. aureus nasal colonization who underwent mupirocin-based decolonization during the study period. A decolonized neonate was defined as a neonate with ≥1 negative culture after intranasal mupirocin treatment. Pulsed-field gel electrophoresis was used for strain typing.

resultsOf 2,060 infants screened for S. aureus, 271 (13%) were colonized, and 203 of these 271 (75%) received intranasal mupirocin. Of those treated, 162 (80%) had follow-up surveillance cultures, and 63 of these 162 infants (39%) developed recurrent colonization after treatment. The S. aureus strains were often genetically similar before and after decolonization. The presence of an endotracheal tube or nasal cannula/mask was associated with an increased risk of recurrent S. aureus colonization (hazard ratio [HR], 2.65; 95% confidence interval [CI], 1.19-5.90; and HR, 2.21; 95% CI, 1.02-4.75, respectively).

conclusionStrains identified before and after decolonization were often genetically similar, and the presence of invasive respiratory devices increased the risk of recurrent S. aureus nasal colonization in neonates. To improve decolonization efficacy, alternative strategies may be needed.

Indexed as

Administration, IntranasalAnti-Bacterial AgentsBaltimoreCarrier StateCross InfectionDisinfectionFemaleHumansInfantInfant, NewbornIntensive Care Units, NeonatalMaleMupirocinOdds RatioRetrospective StudiesRisk FactorsAnti-Bacterial AgentsMupirocin

Identifiers

PMID30226122
PMCPMC6188792
OpenAlexW2891688417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.